The researchers compare genetic markers, people???s ages, medical histories, and other factors to figure out which patients will most likely benefit from the vaccine. ???In the past, we would form a hypothesis and say, ???We think these three biomarkers are important,????????? says Amanda Enstrom, a research scientist at BN ImmunoTherapeutics. ???With Ayasdi, we really allow the data to show us wh